JNJ

Recent Articles

5 Stocks With Strong Earnings Growth — MIL MA MXWL AEGN JNJ

This week, these five stocks have the best ratings in Earnings Growth, one of the eight Fundamental Categories on Portfolio Grader. More 

Finding Values in a REIT Bubble

Low rates have made investors hungry for yield and that can lead them directly to REITs. But be careful as some REIT valuations are off the mark today More 

It’s Time to Stare Risk in the Face

If you're going to think about what you're willing to lose for your investment strategy, there's no better time than when you actually have something to lose. More 

4 Pharmaceutical Stocks to Buy Now

Four Pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). More 

Don’t Chase Bond Safety With More Risk

Investors continue to roll money out of stocks and stock funds and into bond funds, but many might not understand the risks in that retirement strategy. More 

Why I Won’t Sell Dividend Stocks Even After a 1000% Gain

Selling out of a position in dividend stocks, even with a 1,000% gain, is a tricky if you believe in the business and its future potential. Here's why. More 

5 Stocks With Great Earnings Growth — MIL MA MXWL AEGN JNJ

This week, these five stocks have the best ratings in Earnings Growth, one of the eight Fundamental Categories on Portfolio Grader. More